EW Edwards Lifesciences Corporatio | US28176E1082
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 7.422.777.380 | 6.755.586.360 | 9.88% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 3,37 | 3,00 | 12.49% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 27 | 27 | 0.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |